Table 2.
Risk Factor Analysis.
| Risk factors | SNPs | Causal effects of MASH on risk factors by IVW | Heterogeneity | Pleiotropy | |||
|---|---|---|---|---|---|---|---|
| n | 95% CI | p-Value | Q-statistic | p-Value | MR-Egger intercept | p-Value | |
| BMI | 39 | −0.018 (−0.033 to 0.012) | 0.455 | 525.133 | <0.001 | 0.006 | 0.233 |
| Total cholesterol | 37 | −0.009 (−0.021 to 0.023) | 0.877 | 359.228 | <0.001 | 0.015 | 0.412 |
| Total triglycerides | 41 | 0.010 (−0.028 to 0.045) | 0.651 | 879.254 | <0.001 | 0.011 | 0.597 |
| T2DM | 25 | 0.101 (−0.025 to 0.223) | 0.173 | 225.293 | <0.001 | 0.009 | 0.237 |
| Insulin resistance | 33 | 0.028 (0.017 to 0.045) | 0.006 | 189.476 | <0.001 | 0.004 | 0.629 |
| Alcohol consumption | 39 | −0.006 (−0.019 to 0.010) | 0.726 | 285.991 | <0.001 | 0.003 | 0.256 |
| Tobacco smoking | 40 | 0.008 (−0.012 to 0.014) | 0.318 | 192.123 | <0.001 | 0.008 | 0.365 |
BMI: body mass index; CI: confidence interval; SNP: single-nucleotide polymorphism; IVW: inverse variance–weighted; MASH: metabolic dysfunction–associated steatohepatitis; MR: Mendelian randomization; T2DM: type 2 diabetes.